Neuropathy patients more likely to receive high-cost, low-yield screening instead of more effective tests
Monday, January 23, 2012 - 21:30
in Health & Medicine
Researchers found more efficient diagnostic tools are not always used.
Updated by artificial intelligence Sat, 3 Jan 2026, 15:40:35 UTC Learn more
- Tell your friends
- Get science news via